Hinova Pharmaceuticals Inc. (SHA:688302)
35.45
+2.37 (7.16%)
At close: Nov 5, 2026
| Market Cap | 3.51B -26.5% |
| Revenue (ttm) | 82.85M +250.9% |
| Net Income | -138.63M |
| EPS | -1.41 |
| Shares Out | 99.02M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,292,227 |
| Open | 36.00 |
| Previous Close | 33.08 |
| Day's Range | 34.81 - 37.97 |
| 52-Week Range | 26.53 - 60.00 |
| Beta | -0.01 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 31, 2026 |